Italfarmaco Shares a New Issue of Community Newsletter

October 21, 2020

Italfarmaco shares the latest issue of their community newsletter including updates on EPIDYS Phase 3 Trial and Givinostat. Read their newsletter here.

Experience the magic this summer!

How is the rare disease community accomplishing goals?

Tune in on February 29 to hear from our panel and moderators on how they are accomplishing goals and living life to the fullest!

Your gift helps Jett Foundation provide programming and opportunities, such as Camp Promise, to many families impacted by Duchenne muscular dystrophy each year.

Accessible Vehicle Fund Applications Open